Effect of Anti CD20 in Pemphigus Desease

University Hospital, Rouen

Status and phase: Completed; Phase 3; Phase 2

Conditions: Pemphigus

Treatments: Drug: Mabthera

Study type: Interventional

Funder types: Other

Identifiers

NCT00213512

2002/020/HP

Details and patient eligibility

About

to treat in an open non comparative clinical study patients presenting pemphigus with corticodependance, corticoresistance and contre-indication to systemic steroids.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age>18
• pemphigus corticoresistant
• pemphigus cortico dependant
• contre-indications : systémic steroids

Exclusion criteria

• age < 18
• cardiopathie
• pregnant woman
• absence contraception
• no consentment

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)